BridgeBio Pharma Inc. (BBIO) Misses Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Join SI Premium – FREE
BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q3 EPS of ($1.06), $0.16 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- Wolfe Research Upgrades Grainger (GWW) to Peerperform (correction)
- GitLab updates consumption revenue metric, CRR surpasses $20M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
